Leadership

Driven by experience. Guided by purpose.

A dynamic leadership team dedicated to innovation, operational excellence, and impactful decision-making — united by the mission to revolutionize healthcare diagnostics.

Executives

Board Members

SAB Advisors

National

Reach

Executive team

The people driving innovation forward.

06 principals

CEO

Chief Executive Officer & Co-Founder

Jenna Anderson

Jenna Anderson is the Co-Founder and Chief Executive Officer of Kihealth, where she leads the company's strategy, commercialization, fundraising, and growth initiatives. With more than two decades of experience spanning healthcare, biotechnology, digital health, and consumer wellness, Jenna has built and scaled innovative organizations at the intersection of science and technology. Prior to Kihealth, she held executive leadership positions with AccessElite, Concierge Key Health, ALPHAEON Corporation, and Allergan, where she led sales, marketing, product development, and commercialization initiatives. Jenna is passionate about transforming healthcare through earlier detection, prevention, and precision diagnostics, and has dedicated her career to bringing innovative healthcare solutions to patients, providers, and health systems worldwide. (CXO Magazine)

Strategic VisionGrowth LeadershipInvestor Relations

Strategy

Focus

Diagnostics

Mission

National

Reach

COO & CO-founder

Chief Operations Officer & CO-founder

Robert E. Mons III

Robert E. Mons III is the Co-Founder and Chief Operations Officer of Kihealth, where he oversees operations, business development, strategic partnerships, government affairs, and corporate growth initiatives. Prior to co-founding Kihealth, Robert spent six years serving in the United States Congress and later held senior leadership positions within Florida state government, providing extensive experience in healthcare policy, public affairs, and regulatory strategy. He is also the founder of Monstrong Fitness, a health and wellness company focused on performance optimization, and has served in executive leadership roles within Islet Sciences and Meraki Capital. Robert's experience spans healthcare innovation, diagnostics commercialization, fundraising, corporate strategy, and strategic partnerships, helping position Kihealth at the forefront of disease interception and precision medicine.

OperationsProcess ImprovementRegulatory Compliance

Operations

Focus

Scalable

Approach

Excellence

Standard

CMO

Chief Medical Officer

Dr. Matthew R. Benson, MD

Dr. Matthew Benson is a board-certified pediatric endocrinologist and nationally recognized diabetes specialist. He serves as Medical Director of the Northeast Florida Pediatric Diabetes Center at Nemours Children's Health and has extensive experience in pediatric diabetes, obesity, endocrinology, and clinical research. Dr. Benson has participated in numerous clinical trials and translational research programs focused on improving outcomes for patients with metabolic disease and Type 1 diabetes. As Chief Medical Officer of Kihealth, he provides clinical leadership across research, regulatory strategy, physician engagement, and product development while helping guide the company's scientific and clinical initiatives. (Bible Gateway)

Board-certifiedClinical StrategyPatient Care

Clinical

Focus

Medical

Standard

Evidence

Approach

CSO

Chief Scientific Officer

Dr. Clifford Morris, PhD

Dr. Clifford Morris is a molecular biologist and diagnostics innovator with extensive experience in biomarker discovery, translational research, assay development, and precision medicine. As Chief Scientific Officer of Kihealth, he leads scientific strategy, research collaborations, platform expansion, and product development initiatives. Dr. Morris has dedicated his career to advancing novel molecular technologies capable of identifying disease earlier and more accurately. His expertise spans molecular diagnostics, biomarker validation, clinical research, and the translation of scientific discoveries into commercial healthcare solutions.

PhDR&D LeadershipScientific Integrity

R&D

Focus

Rigorous

Approach

Innovation

Standard

Lab Dir

Laboratory Director

Dr. Ioan Cucoranu, MD, FCAP

Dr. Ioan Cucoranu is an accomplished laboratory physician, molecular diagnostician, and laboratory operations leader. As Laboratory Director for Kihealth, he oversees clinical laboratory operations, quality systems, assay implementation, and regulatory compliance. Dr. Cucoranu brings extensive expertise in molecular pathology, laboratory medicine, clinical validation, and high-complexity laboratory management. His leadership ensures that Kihealth maintains the highest standards of scientific rigor, analytical performance, and operational excellence.

MD, FCAPCLIA CertifiedQuality Assurance

Quality

Focus

CLIA

Cert

Accuracy

Standard

VP R&D

Vice President, Research & Development

Marshall Jaroch

Marshall Jaroch leads research and development efforts at Kihealth and plays a critical role in assay development, analytical validation, platform optimization, and translational research. He has been instrumental in advancing Kihealth's disease interception technologies and expanding the company's molecular diagnostics platform. Marshall's expertise spans molecular biology, laboratory research, product development, assay validation, and commercialization, helping bridge scientific innovation with real-world clinical application.

PhDValidationMethodology

Research

Focus

Validation

Approach

Rigor

Standard

Scientific Advisory Board

A standing council of field-defining scientists.

The SAB convenes to guide program data review, biomarker discovery, and clinical study design — bringing world-class expertise across diabetes, endocrinology, cell transplantation, and biotech strategy.

SAB / 01

Eitan Akirav, Ph.D.

Scientific Advisor

Director of Business Development, Harvard University

Dynamic biotech leader with a dual focus on scientific innovation and business strategy.

SAB / 02

Dr. Camillo Ricordi

Scientific Advisor

Director Emeritus, Diabetes Research Institute & Cell Transplant Center, University of Miami

Internationally renowned physician-scientist and pioneer in diabetes research, regenerative medicine, and cellular transplantation. Director Emeritus of the Diabetes Research Institute at the University of Miami Miller School of Medicine, Dr. Ricordi has authored hundreds of peer-reviewed publications and is widely recognized for advancing islet transplantation, diabetes prevention, and translational medicine.

SAB / 03

Dr. Kevan Herold

Scientific Advisor

Professor of Immunobiology & Medicine, Yale School of Medicine

Globally recognized physician-scientist and one of the world's leading experts in Type 1 diabetes prevention and immunotherapy. His research contributed to the development of teplizumab, the first FDA-approved therapy shown to delay the onset of Type 1 diabetes. Dr. Herold has spent decades advancing autoimmune disease research, beta-cell preservation, and disease interception.

SAB / 04

Dr. Larry Fox

Clinical Advisor

Chief of Pediatric Endocrinology, Nemours Children's Health

Nationally recognized pediatric endocrinologist with more than 34 years of experience in pediatric endocrinology and diabetes care. Dr. Fox has led clinical research, physician education, and multidisciplinary diabetes programs, and provides Kihealth with clinical insight into pediatric diabetes, disease progression, and the integration of novel diagnostic technologies into clinical practice.

SAB / 05

Dr. Shadi Abdelnour

Clinical Advisor

Endocrinologist, Cedars-Sinai Medical Center

Board-certified endocrinologist at Cedars-Sinai Medical Center with more than 20 years of clinical experience in diabetes, obesity, insulin resistance, dyslipidemia, and metabolic disease. Dr. Abdelnour combines evidence-based care with advances in precision medicine, contributing expertise in therapeutic intervention and the clinical application of biomarkers designed to identify disease earlier.

Board of Directors

Independent oversight. Operator pedigree.

Kihealth's board pairs deep capital-markets discipline with operators who have scaled category-defining companies — guiding strategy, governance, and long-horizon value creation as we build the platform for disease interception.

BOD / 01Chairman of the Board

Scott A. Blum

Founder, ThinkTank Holdings · Founder, Buy.com

Visionary entrepreneur and founder of ThinkTank Holdings LLC (1999), a private investment firm focused on technology, commerce, and media. Scott founded Buy.com — one of the earliest and most successful e-commerce platforms — and has scaled ventures including Luxury Card and Dutch Design. His expertise in scaling companies, optimizing operations, and driving disruption positions Kihealth at the intersection of healthcare and technology.

ScalingCapital strategyDisruption

BOD / 02Board Member

Parker Kelley, CPA

Kramer-Wilson Company · fmr. CFO, KW Specialty Insurance

Seasoned financial strategist and California CPA with a career spanning corporate finance, public accounting, and investment management. Parker has been instrumental at Kramer-Wilson Company (consolidated assets ~$618M as of Dec 2023). As founding CFO of KW Specialty Insurance, he built the company to a $101M statutory surplus and an A.M. Best A- (Excellent) rating. Previously at Warner Music Group and Holthouse Carlin & Van Trigt.

Fiscal strategyOperationsInvestment structuring

BOD / 03Board Member

Cameron Gray, PhD, JD

Founder & CEO, Alcedo Capital · fmr. MD, MDB Capital Group

Distinguished biotechnology and investment leader. Founder and CEO of Alcedo Capital (2019); previously Managing Director at MDB Capital Group funding disruptive technology companies, and Senior Investment Banker at Paulson Investment Company. Former CEO and board member of Endeavor IP, Inc. and SVP at ICAP Patent Brokerage. PhD in Biophysics (University of Virginia), JD (George Washington University Law School), BA in Physics (Princeton).

BiotechCapital marketsIP strategy

Build with us

We are hiring scientists and operators who want to revolutionize diagnostics.

Open roles Contact leadership